These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 22820591)
1. [Association of cellular inhibitor of apoptosis protein-2 expression with clinical outcomes of hepatocellular carcinoma]. Bi M; Yang D; Li X; Zhong K; Liu Y; Li G; Liao X; Liu X Nan Fang Yi Ke Da Xue Xue Bao; 2012 Jun; 32(7):1020-5, 1030. PubMed ID: 22820591 [TBL] [Abstract][Full Text] [Related]
2. [Relationship between expression of decoy receptor 3 and apoptosis in hepatocellular carcinoma]. Chen G; Luo DZ; Wang Y; Liao ZL; Zhang MY Zhonghua Bing Li Xue Za Zhi; 2007 Feb; 36(2):113-7. PubMed ID: 17493386 [TBL] [Abstract][Full Text] [Related]
3. [Expression of special AT-rich sequence-binding protein 1 mRNA in hepatocellular carcinoma and its clinical significance]. Peng ZK; Yang DH; Li XH; Huang Y; Zhang GQ; Zhong KB; Bi MP; Li GH Nan Fang Yi Ke Da Xue Xue Bao; 2011 Jun; 31(7):1207-11. PubMed ID: 21764697 [TBL] [Abstract][Full Text] [Related]
4. [The expression and significance of heparanase and nm23-H1 in hepatocellular carcinoma]. Liu Y; Chen X; Peng S; Fang H; Wu Y; Peng C; Shi L; Bai M; Xu B; Wang J; Deng G Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(22):1553-6. PubMed ID: 12609066 [TBL] [Abstract][Full Text] [Related]
5. [Relationship between the expressions of indoleamine 2, 3-dioxygenase in hepatocellular carcinoma and clinicopathological parameters]. Lin L; Yang DH; Huang Y; Li XH; Zhang QL; Liu X; Liang JK; Zhong KB; He H Zhonghua Yi Xue Za Zhi; 2013 Jul; 93(28):2186-90. PubMed ID: 24169325 [TBL] [Abstract][Full Text] [Related]
6. [Expression and significance of EGF mRNA and EGFR mRNA in hepatocellular carcinoma]. Zhao YN; Cao J; Wu FX; Ou C; Yuan WP; Mo QG; Wei W; Li Y; Su JJ; Liang AM Ai Zheng; 2004 Jul; 23(7):762-6. PubMed ID: 15248908 [TBL] [Abstract][Full Text] [Related]
7. Role of tissue factor in hepatocellular carcinoma genesis, invasion and metastasis. Zhou Q; Huang T; Wang YF; Zhou XB; Liang LJ; Peng BG Chin Med J (Engl); 2011 Nov; 124(22):3746-51. PubMed ID: 22340235 [TBL] [Abstract][Full Text] [Related]
8. [Expression and clinical significance of metastasis-associated in colon cancer 1 (MACC1) in HBV-related hepatocellular carcinoma]. Chang XJ; Wang CP; Qu JH; Lu YY; Chen Y; Bai WL; Gao XD; Hao LY; Xu GL; Wang H; Yang YP Zhonghua Zhong Liu Za Zhi; 2012 Oct; 34(10):748-52. PubMed ID: 23291068 [TBL] [Abstract][Full Text] [Related]
9. Expression and clinical significance of TAp73alpha, p53, PCNA and apoptosis in hepatocellular carcinoma. Qin HX; Nan KJ; Yang G; Jing Z; Ruan ZP; Li CL; Xu R; Guo H; Sui CG; Wei YC World J Gastroenterol; 2005 May; 11(18):2709-13. PubMed ID: 15884108 [TBL] [Abstract][Full Text] [Related]
10. The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection. Chen D; Xing W; Hong J; Wang M; Huang Y; Zhu C; Yuan Y; Zeng W Ann Surg Oncol; 2012 Oct; 19(11):3556-65. PubMed ID: 22588469 [TBL] [Abstract][Full Text] [Related]
11. [Significance of glypican-3 mRNA expression in hepatocellular carcinoma tissues and peripheral blood cells]. Li BD; Zhao QC; Zhu YT; Zhang FQ; Dou KF Zhonghua Wai Ke Za Zhi; 2006 Apr; 44(7):458-62. PubMed ID: 16772080 [TBL] [Abstract][Full Text] [Related]
12. Loss of p57 expression and RhoA overexpression are associated with poor survival of patients with hepatocellular carcinoma. Hu T; Guo H; Wang W; Yu S; Han L; Jiang L; Ma J; Yang C; Guo Q; Nan K Oncol Rep; 2013 Oct; 30(4):1707-14. PubMed ID: 23842948 [TBL] [Abstract][Full Text] [Related]
13. [Study on the prognostic value of hepatocyte growth factor and c-met for patients with hepatocellular carcinoma]. Wu FS; Zheng SS; Wu LJ; Ding W; Ma ZM; Wang ZM; Teng LS; Zhao WH Zhonghua Wai Ke Za Zhi; 2006 May; 44(9):603-8. PubMed ID: 16784653 [TBL] [Abstract][Full Text] [Related]
14. [Expression and significance of tumor susceptibility gene 101 in hepatocellular carcinoma tissues]. Gu RJ; Wang SC; Sun G; Zhuang BW; Liu DL Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Jul; 28(7):738-40. PubMed ID: 22768867 [TBL] [Abstract][Full Text] [Related]
15. High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and beta-catenin mutations. Peng SY; Chen WJ; Lai PL; Jeng YM; Sheu JC; Hsu HC Int J Cancer; 2004 Oct; 112(1):44-50. PubMed ID: 15305374 [TBL] [Abstract][Full Text] [Related]
16. [Expression and significance of epidermal growth factor receptor variant type III in hepatocellular carcinoma]. Ou C; Wu FX; Luo Y; Cao J; Zhao YN; Yuan WP; Li Y; Su JJ Ai Zheng; 2005 Feb; 24(2):166-9. PubMed ID: 15694026 [TBL] [Abstract][Full Text] [Related]
17. [CK19 can be used to predict the early recurrence and prognosis of HBV-related hepatocellular carcinoma patients with low AFP serum concentration after R0 radical hepatectomy]. Wang ZS; Wu LQ; Yi X; Geng C; Li YJ; Yao RY; Hu WY; Han B Zhonghua Zhong Liu Za Zhi; 2012 Oct; 34(10):753-8. PubMed ID: 23291069 [TBL] [Abstract][Full Text] [Related]
18. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis. Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703 [TBL] [Abstract][Full Text] [Related]
19. Metastasis-related miR-185 is a potential prognostic biomarker for hepatocellular carcinoma in early stage. Zhi Q; Zhu J; Guo X; He S; Xue X; Zhou J; Hu B; Li H; Chen S; Zhao H; Kuang Y Biomed Pharmacother; 2013 Jun; 67(5):393-8. PubMed ID: 23648054 [TBL] [Abstract][Full Text] [Related]
20. [Expression and its clinicopathological features of tumor rejective antigen 1 in human tissues of hepatocellular carcinoma and liver cirrhosis]. Zhang H; Huang DF; Wei Q; Hua TY; Li F; Huang JF Zhonghua Gan Zang Bing Za Zhi; 2010 Sep; 18(9):661-5. PubMed ID: 20943076 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]